NOVADIP Biosciences, a #Belgian late-stage clinical #BioTech company specialising in #regenerative #medicine, has closed a €10.4 million convertible #financing round. 🇧🇪 🧬 🦴
https://t.co/v0coHkOc2D https://t.co/JKnKw1cCNd
https://t.co/v0coHkOc2D https://t.co/JKnKw1cCNd

4
Immitra Bio, a Zürich-based #genetic #medicine platform bringing scalability and commercial viability to #gene #editing #therapies, has announced the completion of an upsized €2.58 million pre-Seed #financing round. 🇨🇭🧬🔬
https://t.co/DWrgg6MlsQ
https://t.co/DWrgg6MlsQ
1
You’ve reached the end 🎉
